Diagnostic Accuracy of MRS in the Preoperative Identification of Isocitrate Dehydrogenase Mutation in Patients with Gliomas

Diagnostic Accuracy of MRS in the Preoperative Identification of Isocitrate Dehydrogenase Mutation in Patients with Gliomas

Bibliographic Details
Main Authors:	Fahad Alkherayf, Thanh Nguyen, Gerd Melkus, Ryan Gotfrit, Carlos H. Torres, Nader Zakhari, Santanu Chakraborty, Gerard Jansen, Mattew D. McInnes, Rafael Ochoa-Sanchez, Rebecca E. Thornhill, Ian Cameron
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529423001443

Similar Items

How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?
by: Eric T Wong
Published: (2023-01-01)

Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
by: Yang Liu, et al.
Published: (2020-08-01)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
by: Marco Gallus, et al.
Published: (2023-07-01)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
by: Dongming Yan, et al.
Published: (2022-06-01)

Mutasi Isocitrate Dehydrogenase 1 dan 2 pada Glioma
by: Ni Putu Sriwidyani
Published: (2020-12-01)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
by: Felix Neumaier, et al.
Published: (2023-03-01)

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01)

Vorasidenib: A promising therapeutic breakthrough for diffuse isocitrate dehydrogenase mutant gliomas
by: Abdul Wahid, et al.
Published: (2023-08-01)

Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
by: Auezova R, et al.
Published: (2019-04-01)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
by: Yanfei Jia, et al.
Published: (2021-01-01)

Analysis of Isocitrate dehydrogenase (IDH) mutation in Gliomas---a call for neurosurgeons and pathologists in Pakistan
by: Muntaha Masood, et al.
Published: (2022-05-01)

Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01)

Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
by: Ming-Yang Li, et al.
Published: (2015-01-01)

Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
by: Lei-Ming Wang, et al.
Published: (2019-12-01)

The studies on the mechanism and inhibition of Isocitrate Dehydrogenases
by: Liu, X
Published: (2022)

Mutant Isocitrate Dehydrogenase 1 Expression Enhances Response of Gliomas to the Histone Deacetylase Inhibitor Belinostat
by: Chi-Ming Chang, et al.
Published: (2023-05-01)

Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients
by: Chong‐Xiao Qu, et al.
Published: (2020-04-01)

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
by: Li Su, et al.
Published: (2020-04-01)

Histologic characterization of the immune infiltrate in isocitrate dehydrogenase wild-type and mutant World Health Organization Grade II and III gliomas
by: Josine A. E. M. Jansen, et al.
Published: (2018-01-01)

The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
by: Tomoaki Ishida, et al.
Published: (2021-12-01)

Mechanistic and inhibition studies on isocitrate dehydrogenase 1
by: Liu, S
Published: (2019)

Rapid detection of isocitrate dehydrogenase 1 mutation status in glioma based on Crispr-Cas12a
by: Zhebin Feng, et al.
Published: (2023-04-01)

TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma
by: Mengqi Gao, et al.
Published: (2021-04-01)

Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
by: Xiaoran Zhang, et al.
Published: (2019-01-01)

Preoperative Predictors of Early Mortality Risk in Isocitrate Dehydrogenase-Wild-Type Glioblastoma Patients Treated with Standard Therapy
by: Zhao C, et al.
Published: (2021-02-01)

The Association of Alpha-thalassemia X-Linked Intellectual Disability Mutation with Histopathological Grading in Isocitrate- Dehydrogenase-mutant Glioma
by: Alva Sinung Anindita, et al.
Published: (2023-12-01)

The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
by: Philip Dao Trong, et al.
Published: (2023-04-01)

How successful is the volumetric ADC value in forecasting isocitrate dehydrogenase mutation status of adult-type diffuse glioma?
by: Suna Sahin Ediz, et al.
Published: (2023-04-01)

Assessment of Isocitrate Dehydrogenase 1 Genotype and Cell Proliferation in Gliomas Using Multiple Diffusion Magnetic Resonance Imaging
by: Yan Xie, et al.
Published: (2021-11-01)

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
by: Genglin Jin, et al.
Published: (2011-02-01)

Functional analysis of mutations in isocitrate dehydrogenase involved in gliomagenesis
by: Krell, D
Published: (2014)

Studies on human cancer variant and mycobacterial isocitrate dehydrogenases
by: Reinbold, R
Published: (2021)

Isocitrate dehydrogenase gene variants in cancer and their clinical significance
by: Cadoux-Hudson, T, et al.
Published: (2021)

Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
by: Hvinden, IC, et al.
Published: (2021)

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
by: Yang Liu, et al.
Published: (2023-04-01)

Research Progress of Isocitrate Dehydrogenase Gene Mutation Therapy
by: LIN Meijia, et al.
Published: (2023-03-01)

Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
by: Danielle Golub, et al.
Published: (2019-05-01)

Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
by: Hamoud Al-Khallaf
Published: (2017-08-01)

Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma
by: Shouchao Wang, et al.
Published: (2022-01-01)

Prognostic value of mutations in isocitrate dehydrogenase 1 (IDH1) and reverse telomerase transcriptase (TERT) in Argentine patients` gliomas
by: Pedro Tomás Funes, et al.
Published: (2021-03-01)